Numerous linked cases of acute genotype F hepatitis B virus infections in people living with HIV or on pre-exposure prophylaxis.
OBJECTIVES At least 2.7 million people living with HIV are infected with HBV worldwide. Some antiretroviral treatments and tenofovir disoproxil fumarate-based Pre-Exposure Prophylaxis (PrEP) protect against HBV infection. However, emerging antiretroviral (ARV) strategies without any activity against HBV may promote spr...